Mori, K.; Yamasaki, K.; Morimoto, Y.; Kinoshita, T.; Asai, S.; Arai, T.; Iinuma, T.; Yonekura, S.; Hanazawa, T.
Noteworthy Factors to Decide Therapeutic Strategy for Carcinoma ex Pleomorphic Adenoma of Parotid Gland: A Preliminary Study Statistical Analysis of 22 Cases from Single Institution. Life 2022, 12, 1685.
https://doi.org/10.3390/life12111685
AMA Style
Mori K, Yamasaki K, Morimoto Y, Kinoshita T, Asai S, Arai T, Iinuma T, Yonekura S, Hanazawa T.
Noteworthy Factors to Decide Therapeutic Strategy for Carcinoma ex Pleomorphic Adenoma of Parotid Gland: A Preliminary Study Statistical Analysis of 22 Cases from Single Institution. Life. 2022; 12(11):1685.
https://doi.org/10.3390/life12111685
Chicago/Turabian Style
Mori, Kosei, Kazuki Yamasaki, Yuki Morimoto, Takashi Kinoshita, Shunichi Asai, Tomoyuki Arai, Tomohisa Iinuma, Syuji Yonekura, and Toyoyuki Hanazawa.
2022. "Noteworthy Factors to Decide Therapeutic Strategy for Carcinoma ex Pleomorphic Adenoma of Parotid Gland: A Preliminary Study Statistical Analysis of 22 Cases from Single Institution" Life 12, no. 11: 1685.
https://doi.org/10.3390/life12111685
APA Style
Mori, K., Yamasaki, K., Morimoto, Y., Kinoshita, T., Asai, S., Arai, T., Iinuma, T., Yonekura, S., & Hanazawa, T.
(2022). Noteworthy Factors to Decide Therapeutic Strategy for Carcinoma ex Pleomorphic Adenoma of Parotid Gland: A Preliminary Study Statistical Analysis of 22 Cases from Single Institution. Life, 12(11), 1685.
https://doi.org/10.3390/life12111685
